About Pricing FAQs Providers Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clinical Trials in Miami | 11,431 Studies Near You | Clareo Health

Clinical Trials LocationsMiami

Clinical Trials in Miami

Discover 11,431 clinical trials near Miami, Florida. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Filters

Sort by

Status

Recruiting(Enrolling)

Not yet recruiting

Active, not recruiting

Enrolling by invitation(Enrolling)

Completed

Terminated

Phase

Early Phase 1

Phase 1

Phase 1/Phase 2

Phase 2

Phase 2/Phase 3

Phase 3

Phase 4

Not Applicable

Eligibility

Accepts healthy volunteers

Showing 10861-10880 of 11,431 trials

TERMINATEDPhase 2< 1 mile

A 2 Week Blinded Study For Pain Due To Arthritis Of The Knee

NCT00483977

The primary aim is to assess if PF-00592379 is able to reduce pain in patients with osteoarthritis of the knee.

Pfizer113 participantsStarted Jun 2007

Mobile, Alabama, United States • Tucson, Arizona, United States • Carmichael, California, United States +18 more locations

COMPLETEDPhase 3< 1 mile

A Study of Dexlansoprazole Modified Release Formulation to Treat Night Heartburn

NCT00627016

The purpose of this study is to determine whether Dexlansoprazole once daily (QD) is effective in treating patients with night heartburn.

Gastroesophageal Reflux

Takeda305 participantsStarted Mar 2008

Tucson, Arizona, United States • Anaheim, California, United States • Garden Grove, California, United States +40 more locations

Find Trials by Condition in Miami

Breast Cancerin Miami Lung Cancerin Miami Prostate Cancerin Miami Colorectal Cancerin Miami Melanomain Miami Leukemiain Miami Lymphomain Miami Pancreatic Cancerin Miami Ovarian Cancerin Miami Brain Cancerin Miami Diabetesin Miami

Data from ClinicalTrials.govTerms

COMPLETEDPhase 4< 1 mile

Safety Of VIRACEPT® 625mg Administered To HIV-Infected Women During Pregnancy

NCT00246610

This study is an evaluation of the safety of 625 mg formulation when administered to HIV-infected pregnant women from their second trimester through six weeks postpartum. The study will also evaluate the pharmacokinetics of VIRACEPT

Pfizer16 participantsStarted Mar 2006

Jacksonville, Florida, United States • Miami, Florida, United States • Metairie, Louisiana, United States +3 more locations

COMPLETEDPhase 3< 1 mile

Comparison of Two Anti-HIV Regimens That Include One of Two Forms of Didanosine (ddI)

NCT00002224

Didanosine is an effective anti-HIV drug, but it can cause stomach upset. This study tests a new form of didanosine, ddI EC, a coated pill that passes through the stomach more easily and hopefully will prevent stomach upset. The purpose of this study is to compare the effectiveness of ddI EC versus the standard form of ddI. Both forms of ddI will be given with stavudine (d4T) plus nelfinavir (NLF).

Bristol-Myers Squibb120 participantsStarted Mar 1999

Birmingham, Alabama, United States • Los Angeles, California, United States • Oakland, California, United States +21 more locations

COMPLETEDNA< 1 mile

A Comparison of External Mechanical Work Between Different Prosthetic Feet

NCT01340807

Recent dysvascular and diabetic amputees as well as older, long-term traumatic amputees are at risk of functional decline, joint degeneration, skin breakdown and further limb loss due to the forces placed on the contralateral limb through prosthetic ambulation. If specialized prosthetic gait training and proper use of the appropriate prosthetic foot can decrease forces on the intact limb, the long term health and quality of life of veterans with amputations could be substantially improved. We will address two key questions: Key Question 1: After receiving specialized gait training and a new prosthetic socket, will subjects demonstrate differences in gait symmetry and external mechanical work between the bionic and conventional prosthetic feet, while performing various functional activities. Key Question 2: Can external mechanical work be used as a clinically friendly measure to differentiate between prosthetic feet?

Traumatic Amputation of Lower Extremity

Miami VA Healthcare System15 participantsStarted Mar 2008

Miami, Florida, United States

COMPLETEDNA< 1 mile

A Comparison of Two Triple-Drug Combinations in Patients Who Have Never Been Treated With Anti-HIV Drugs

NCT00002411

The purpose of this study is to compare the safety of didanosine plus stavudine plus nelfinavir (NLF) with that of zidovudine plus lamivudine plus NLF. This study also examines how long these drug combinations are effective in lowering viral load (level of HIV in the blood).

Bristol-Myers SquibbStarted Mar 1998

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Fresno, California, United States +29 more locations

COMPLETEDPhase 2< 1 mile

A Study To Measure The Level Of Drug In Nasal Tissue And Blood After Taking A Single 2g Dose Or 500mg Tablets For Up To

NCT00232154

To measure the level of drug in nasal tissue and blood after taking a single 2g dose or 500mg tablets for up to 3 days.

Pfizer72 participantsStarted Nov 2005

Alabaster, Alabama, United States • Birmingham, Alabama, United States • Birmingham, Alabama, United States +15 more locations

COMPLETEDPhase 3< 1 mile

One-Year Safety and Tolerability Study of Azilsartan Medoxomil in Participants With Essential Hypertension

NCT00695955

This purpose of this study is to evaluate the long-term safety and tolerability of azilsartan medoxomil in individuals with essential hypertension.

Takeda669 participantsStarted Jun 2007

Ozark, Alabama, United States • Tallassee, Alabama, United States • Long Beach, California, United States +38 more locations

COMPLETEDPhase 3< 1 mile

An Efficacy and Safety Study of Azilsartan Medoxomil Compared to Valsartan and Olmesartan in Participants With Essential Hypertension.

NCT00696436

The purpose of this study is to evaluate the efficacy and safety of azilsartan medoxomil, once daily (QD), compared to placebo, valsartan and olmesartan in participants with essential hypertension.

Takeda1,291 participantsStarted Apr 2008

Alabaster, Alabama, United States • Ozark, Alabama, United States • Green Valley, Arizona, United States +128 more locations

COMPLETEDPhase 1< 1 mile

Study Evaluating The Potential Effect Of Lansoprazole On The Pharmacokinetics Of Bosutinib In Healthy Subjects

NCT00952913

The purpose of this study is to see if there is an effect on the pharmacokinetics of bosutinib when administered with lansoprazole.

Wyeth is now a wholly owned subsidiary of Pfizer24 participantsStarted Aug 2009

Miami, Florida, United States

COMPLETEDPhase 4< 1 mile

Irbesartan Versus Placebo in Combination With Ramipril for Treatment of Albuminuria

NCT00095290

Albumin in the urine is usually a signal that you might be at risk of cardiovascular complications. The purpose of this study is to determine if the albumin in your urine can be decreased by the treatment regimen that consists of irbesartan taken at the same time with ramipril.

Bristol-Myers Squibb400 participantsStarted Sep 2004

Tustin, California, United States • Miami, Florida, United States • West Palm Beach, Florida, United States +89 more locations

COMPLETED< 1 mile

A Study of Dasatinib to See How Liver Impaired and Healthy Subjects Process and React to the Study Drug

NCT00382668

The primary purpose of this study is to evaluate how a person with liver impairment processes and reacts to the study drug. Information about any side effects that may occur will also be collected.

Bristol-Myers Squibb40 participantsStarted Oct 2006

Miami, Florida, United States • Miramar, Florida, United States • Orlando, Florida, United States +1 more locations

COMPLETED< 1 mile

A Study of Prevalence of the I50L Mutation When ATV Treated Patients Fail the Regimen

NCT00135447

The purpose of this study is to find out the frequency of the I50L substitution among patients experiencing treatment failure on an atazanavir-containing regimen.

Bristol-Myers Squibb5,000 participantsStarted Sep 2004

Phoenix, Arizona, United States • Beverly Hills, California, United States • Beverly Hills, California, United States +81 more locations

COMPLETEDPhase 37.3 miles

Long-Term Safety Of DVS-233 SR In Patients With Major Depressive Disorder

NCT01309542

The study evaluated the long-term safety of Desvenlafaxine Succinate (DVS) Slow Release (SR) during open-label treatment in adult outpatients who had a primary diagnosis of major depressive disorder (MDD). The study also evaluated the long-term response of subjects receiving DVS SR for clinical global evaluation, functionality, general well-being, pain, and absence of depressive symptoms (remission).

Major Depressive Disorder

Pfizer1,403 participantsStarted Aug 2003

Birmingham, Alabama, United States • Mesa, Arizona, United States • Peoria, Arizona, United States +114 more locations

COMPLETEDPhase 37.3 miles

A Pilot Study of Atazanavir/Ritonavir/Efavirenz as a Nucleoside Sparing Regimen

NCT00135343

The purpose of this study is to evaluate the safety and efficacy of a novel nucleoside sparing regimen containing atazanavir, ritonavir and efavirenz, using two different doses of atazanavir.

Bristol-Myers Squibb60 participantsStarted Apr 2004

San Francisco, California, United States • Washington D.C., District of Columbia, United States • Atlantis, Florida, United States +12 more locations

COMPLETEDPhase 453 miles

A Study of Xeloda (Capecitabine) in Women With HER2-Negative Metastatic Breast Cancer

NCT00121836

This single-arm study was designed to evaluate the efficacy and safety of oral Xeloda plus intravenous Avastin as first-line treatment in women with metastatic breast cancer. Patients received Xeloda 1000 mg/m² orally (PO) twice daily (BID) on Days 1-15, and Avastin 15 mg intravenously (IV) on Day 1 of each 3-week cycle. The anticipated time on study treatment was until disease progression or unacceptable toxicity. The target sample size was \<100 individuals.

Hoffmann-La Roche109 participantsStarted Jun 2005

Birmingham, Alabama, United States • Birmingham, Alabama, United States • Birmingham, Alabama, United States +54 more locations

COMPLETEDPhase 1118 miles

Safety and Tolerability of Intravitreal VEGF Trap Formulations in Subjects With Neovacular AMD

NCT00383370

To assess the safety and tolerability of repeated intravitreal (ITV) administration of VEGF Trap.

Neovascular Age Related Macular Degeneration

Regeneron Pharmaceuticals20 participantsStarted Oct 2006

Fort Myers, Florida, United States • Wichita, Kansas, United States • Hagerstown, Maryland, United States +3 more locations

COMPLETEDPhase 3205 miles

International Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Cystic Fibrosis Patients With P. Aeruginosa

NCT00112359

The purpose of this study was to evaluate the safety and efficacy of a 28-day course of aztreonam for inhalation solution (AZLI) in patients with cystic fibrosis (CF) and lung infection due to Pseudomonas aeruginosa (PA).

Cystic Fibrosis

Gilead Sciences166 participantsStarted May 2005

Birmingham, Alabama, United States • Anchorage, Alaska, United States • Phoenix, Arizona, United States +50 more locations

COMPLETEDPhase 4667 miles

CARDIOLITE-413: A Study for Patients Who Had a PCI for an Acute MI

NCT00162331

The purpose of this clinical study is to learn if there are any changes in how blood gets to your heart muscle and if your heart size changed after your heart attack.

Myocardial Infarction

Lantheus Medical Imaging74 participantsStarted Jan 2005

Birmingham, Alabama, United States • Boston, Massachusetts, United States • Nashville, Tennessee, United States +5 more locations

COMPLETEDPhase 4795 miles

Post-PCI:Cardiac Imaging in Patients With Diabetes to Detect Coronary Artery Blockages Previously Opened by Angioplasty

NCT00162357

The purpose of this clinical research study is determine if patients with diabetes that have undergone previous opening of a heart blockage may have a blockage that is not causing any symptoms that may be detected by imaging with Cardiolite.

Diabetes Mellitus, Type 2Coronary Restenosis

Lantheus Medical Imaging106 participantsStarted Apr 2004

Hartford, Connecticut, United States • Waterbury, Connecticut, United States • Grand Rapids, Michigan, United States +5 more locations

PreviousPage 544 of 572Next

Heart Diseasein Miami